Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Urman, et al v. Novelos Therapeutics, Inc. et al
Case Number:
1:10-cv-10394
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
September 12, 2011
Novelos Claims Securities Action Strikes Out
Novelos Therapeutics Inc. argued Friday that a putative class of investors alleging the company misled them about the prospects of a developmental-stage cancer drug had failed for a third time to state a claim, and thus the complaint should be dismissed for good.
-
June 24, 2011
Novelos Shakes Class Action Over Cancer Drug Statements
A Massachusetts federal judge on Thursday tossed a securities class action against Novelos Therapeutics Inc., ruling that the pharmaceutical company's CEO did not mislead investors about the prospects of a developmental-stage cancer drug.